Clinical Trials Logo

Clinical Trial Summary

Bronchospasm during anaesthesia is a rare but potentially life-threatening event. They are classically part of IgE-dependent anaphylaxis but can also occur as an independent clinical entity, triggered by inflammatory factors such as smoking, chronic bronchitis, asthma, overweight and mechanical factors such as tracheal intubation. The etiological diagnosis is currently established during an allergy-anaesthesia consultation after skin testing for drugs used for induction of anaesthesia and antibiotic therapy when it is attributable. The aim of this study was to determine the characteristics that differ between 2 groups: isolated non-allergic bronchospasm and bronchospasm as part of an immediate allergic hypersensitivity reaction.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05025709
Study type Observational
Source Central Hospital, Nancy, France
Contact
Status Completed
Phase
Start date September 1, 2020
Completion date March 31, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT05555134 - INHALATION CHAMBER MANAGEMENT IN PEDIATRICS: EFFICACY OF AN EDUCATIONAL INTERVENTION IN PATIENTS DIAGNOSED WITH BRONCHOSPASM AND THEIR FAMILY CAREGIVERS. Phase 1
Completed NCT00400660 - A First Time In Human Study To Assess The Compound GSK615915 Phase 1
Completed NCT03064659 - Driving Pressure And EFL in Adult Cardiac Surgery N/A
Recruiting NCT02090205 - Mechanical Ventilation During Cardiac Surgery N/A
Completed NCT05360810 - Wei Nasal Jet Tube vs Gastro Laryngeal Tube in Endoscopic Retrograde Cholangiopancreatography N/A
Recruiting NCT05783050 - Wei Nasal Jet Tube vs Nasal Cannula Oxygen Support in Gastrointestinal Endoscopy Patients N/A
Recruiting NCT01488643 - Observational Study on Obese Patients During General Anesthesia N/A
Completed NCT02779595 - Change of Regional Ventilation During Spontaneous Breathing After Lung Surgery N/A
Completed NCT01189396 - Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006 Phase 2
Completed NCT01174732 - Dose-Ranging Study of A006 DPI, in Adult Asthma Patients Phase 2
Completed NCT01156701 - Prophylactic Efficacy of Relenza Against Influenza A and B N/A
Completed NCT00806455 - Exercise-Induced Bronchospasm in Cystic Fibrosis N/A
Completed NCT02419196 - Perioperative Change of Regional Ventilation During Spontaneous Breathing N/A
Completed NCT04373499 - Virtual Teach-to-Goal Education vs. Brief Education for Children N/A
Terminated NCT00634829 - Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction Phase 3
Completed NCT00118716 - A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise Phase 4
Completed NCT00118690 - A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise Phase 4
Terminated NCT03962725 - Avoiding Neuromuscular Blockers to Reduce Complications Phase 4
Recruiting NCT03000413 - Ketamine Efficacy for Acute Severe Bronchospasm in ICU: MACANUDO Trial Phase 2/Phase 3
Completed NCT01188577 - Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics Phase 1/Phase 2